Viewing Study NCT04738292


Ignite Creation Date: 2025-12-24 @ 3:23 PM
Ignite Modification Date: 2025-12-26 @ 1:07 AM
Study NCT ID: NCT04738292
Status: TERMINATED
Last Update Posted: 2024-05-03
First Post: 2021-02-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
Sponsor: University of Wisconsin, Madison
Organization: